• Product nameAnti-SPTLC1 antibody
    See all SPTLC1 primary antibodies
  • Description
    Rabbit polyclonal to SPTLC1
  • SpecificityAt least two isoforms of SPTLC1 are known to exist; this antibody will detect only isoform a. SPTLC1 antibody is predicted to not cross-react with SPTLC2.
  • Tested applicationsSuitable for: WB, ICCmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    A 17 amino acid peptide near the carboxy terminus of Human SPTLC (NP_6406).

  • Positive control
    • Human Lung tissue lysate.



Our Abpromise guarantee covers the use of ab112569 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 53 kDa.
ICC Use a concentration of 5 µg/ml.


  • FunctionSerine palmitoyltransferase (SPT). The heterodimer formed with LCB2 (SPTLC2 or SPTLC3) constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SSSPTA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC3-SSSPTA isozyme uses both C14-CoA and C16-CoA as substrates, with a slight preference for C14-CoA. The SPTLC1-SPTLC2-SSSPTB complex shows a strong preference for C18-CoA substrate, while the SPTLC1-SPTLC3-SSSPTB isozyme displays an ability to use a broader range of acyl-CoAs, without apparent preference.
  • Tissue specificityWidely expressed. Not detected in small intestine.
  • PathwayLipid metabolism; sphingolipid metabolism.
  • Involvement in diseaseDefects in SPTLC1 are the cause of hereditary sensory and autonomic neuropathy type 1A (HSAN1A) [MIM:162400]. The hereditary sensory and autonomic neuropathies are a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN1A is an autosomal dominant axonal neuropathy with onset in the second or third decades. Initial symptoms are loss of pain, touch, heat, and cold sensation over the feet, followed by distal muscle wasting and weakness. Loss of pain sensation leads to chronic skin ulcers and distal amputations.
  • Sequence similaritiesBelongs to the class-II pyridoxal-phosphate-dependent aminotransferase family.
  • Cellular localizationEndoplasmic reticulum membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • HSAN antibody
    • HSAN1 antibody
    • HSN1 antibody
    • LBC1 antibody
    • LCB 1 antibody
    • LCB1 antibody
    • Long chain base biosynthesis protein 1 antibody
    • MGC14645 antibody
    • Serine C palmitoyltransferase antibody
    • Serine palmitoyl CoA transferase 1 antibody
    • Serine palmitoyltransferase 1 antibody
    • Serine palmitoyltransferase long chain base subunit 1 antibody
    • Serine palmitoyltransferase subunit 1 antibody
    • Serine-palmitoyl-CoA transferase 1 antibody
    • SPT 1 antibody
    • SPT1 antibody
    • SPTC1_HUMAN antibody
    • SPTI antibody
    • SPTLC 1 antibody
    • SPTLC1 antibody
    see all

Anti-SPTLC1 antibody images

  • All lanes : Anti-SPTLC1 antibody (ab112569) at 1 µg/ml

    Lane 1 : Human lung tissue lysate
    Lane 2 : Human lung tissue lysate with blocking peptide

    Lysates/proteins at 15 µg per lane.

    Predicted band size : 53 kDa
  • Immunohistochemistry of SPTLC1 in human lung tissue with ab112569 at 5 ug/mL.

References for Anti-SPTLC1 antibody (ab112569)

ab112569 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab112569.
Please use the links above to contact us or submit feedback about this product.